Rx Care

Alzheimer's Disease: Untapped Potential for PharmacyPharmacists can become the perfect partner in the battle against Alzheimer’s disease. Details here.
The year's Top Drugs
The year's Top DrugsSpecialty medications dominate
Analyst: CVS’ OptumRx deal amps up competitionLast month, OptumRx and CVS Pharmacy announced that they are partnering to provide more convenient choices and lower costs for patients.
Are states going too far with painkiller script limits?Arizona has become the latest state to limit opioid prescriptions—a trend that has some healthcare providers and experts concerned.
Generic drugs save U.S. $227 billionGeneric drugs produced $227 billion in savings for the U.S. healthcare system in 2015
Will docs prescribe the new RA biosimilars?While FDA recently approved two new biosimilars for rheumatoid arthritis and other inflammatory diseases, questions remain about how quickly physicians and patients will embrace the new drugs.
Medicare drug spending spike shows need for genericsAn exclusive Associated Press report found that Medicare’s spending on certain drugs soared by 85% in two years.
Study: Biosimilars as safe as branded drugsNew study finds that biosimilar medications for arthritis and other diseases areas safe and effective as their brand-name counterparts.
FDA approves rolapitant to prevent chemotherapy-induced nausea and vomitingRolapitant is a novel NK1 receptor antagonist that maintains >90% receptor binding up to five days after a single 180-mg dose.
FDA warns about oral antifungal use during pregnancyA Danish study has found a possibility of increased risk of miscarriage in pregnant women who use oral fluconazole to treat yeast infections.